275 related articles for article (PubMed ID: 22323829)
21. CD4+ T cells are able to promote tumor growth through inhibition of tumor-specific CD8+ T-cell responses in tumor-bearing hosts.
den Boer AT; van Mierlo GJ; Fransen MF; Melief CJ; Offringa R; Toes RE
Cancer Res; 2005 Aug; 65(15):6984-9. PubMed ID: 16061684
[TBL] [Abstract][Full Text] [Related]
22. Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonists.
Welters MJ; Bijker MS; van den Eeden SJ; Franken KL; Melief CJ; Offringa R; van der Burg SH
Vaccine; 2007 Feb; 25(8):1379-89. PubMed ID: 17123670
[TBL] [Abstract][Full Text] [Related]
23. CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling.
Lindsay RW; Darrah PA; Quinn KM; Wille-Reece U; Mattei LM; Iwasaki A; Kasturi SP; Pulendran B; Gall JG; Spies AG; Seder RA
J Immunol; 2010 Aug; 185(3):1513-21. PubMed ID: 20610651
[TBL] [Abstract][Full Text] [Related]
24. Activation of NLRC4 downregulates TLR5-mediated antibody immune responses against flagellin.
Li W; Yang J; Zhang E; Zhong M; Xiao Y; Yu J; Zhou D; Cao Y; Yang Y; Li Y; Yan H
Cell Mol Immunol; 2016 Jul; 13(4):514-23. PubMed ID: 25914934
[TBL] [Abstract][Full Text] [Related]
25. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses.
Bohnenkamp HR; Papazisis KT; Burchell JM; Taylor-Papadimitriou J
Cell Immunol; 2007 Jun; 247(2):72-84. PubMed ID: 17927969
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic efficacy of antigen-specific vaccination and toll-like receptor stimulation against established transplanted and autochthonous melanoma in mice.
Tormo D; Ferrer A; Bosch P; Gaffal E; Basner-Tschakarjan E; Wenzel J; Tüting T
Cancer Res; 2006 May; 66(10):5427-35. PubMed ID: 16707471
[TBL] [Abstract][Full Text] [Related]
27. Flagellin induces antibody responses through a TLR5- and inflammasome-independent pathway.
López-Yglesias AH; Zhao X; Quarles EK; Lai MA; VandenBos T; Strong RK; Smith KD
J Immunol; 2014 Feb; 192(4):1587-96. PubMed ID: 24442437
[TBL] [Abstract][Full Text] [Related]
28. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
Liu Y; Huang H; Chen Z; Zong L; Xiang J
J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
[TBL] [Abstract][Full Text] [Related]
29. pDNA-lipoplexes engrafted with flagellin-related peptide induce potent immunity and anti-tumour effects.
Faham A; Herringson T; Parish C; Suhrbier A; Khromykh AA; Altin JG
Vaccine; 2011 Sep; 29(40):6911-9. PubMed ID: 21798298
[TBL] [Abstract][Full Text] [Related]
30. Dendritic cells from bench to bedside and back.
Adema GJ
Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
[TBL] [Abstract][Full Text] [Related]
31. Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.
Wei J; Waithman J; Lata R; Mifsud NA; Cebon J; Kay T; Smyth MJ; Sadler AJ; Chen W
J Immunol; 2010 Nov; 185(10):6013-22. PubMed ID: 20956347
[TBL] [Abstract][Full Text] [Related]
32. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
Jasani B; Navabi H; Adams M
Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
[TBL] [Abstract][Full Text] [Related]
33. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
34. The structural basis of flagellin detection by NAIP5: A strategy to limit pathogen immune evasion.
Tenthorey JL; Haloupek N; López-Blanco JR; Grob P; Adamson E; Hartenian E; Lind NA; Bourgeois NM; Chacón P; Nogales E; Vance RE
Science; 2017 Nov; 358(6365):888-893. PubMed ID: 29146805
[TBL] [Abstract][Full Text] [Related]
35. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
Sandler AD; Chihara H; Kobayashi G; Zhu X; Miller MA; Scott DL; Krieg AM
Cancer Res; 2003 Jan; 63(2):394-9. PubMed ID: 12543793
[TBL] [Abstract][Full Text] [Related]
36. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
Hao S; Yuan J; Xiang J
J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
[TBL] [Abstract][Full Text] [Related]
37. Redundant and cooperative interactions between TLR5 and NLRC4 in protective lung mucosal immunity against Pseudomonas aeruginosa.
Tolle L; Yu FS; Kovach MA; Ballinger MN; Newstead MW; Zeng X; Nunez G; Standiford TJ
J Innate Immun; 2015; 7(2):177-86. PubMed ID: 25402425
[TBL] [Abstract][Full Text] [Related]
38. Ribosome-rescuer PELO catalyzes the oligomeric assembly of NOD-like receptor family proteins via activating their ATPase enzymatic activity.
Wu X; Yang ZH; Wu J; Han J
Immunity; 2023 May; 56(5):926-943.e7. PubMed ID: 36948192
[TBL] [Abstract][Full Text] [Related]
39. TLR activation regulates damage-associated molecular pattern isoforms released during pyroptosis.
Nyström S; Antoine DJ; Lundbäck P; Lock JG; Nita AF; Högstrand K; Grandien A; Erlandsson-Harris H; Andersson U; Applequist SE
EMBO J; 2013 Jan; 32(1):86-99. PubMed ID: 23222484
[TBL] [Abstract][Full Text] [Related]
40. Modifying bacterial flagellin to evade Nod-like Receptor CARD 4 recognition enhances protective immunity against Salmonella.
Tourlomousis P; Wright JA; Bittante AS; Hopkins LJ; Webster SJ; Bryant OJ; Mastroeni P; Maskell DJ; Bryant CE
Nat Microbiol; 2020 Dec; 5(12):1588-1597. PubMed ID: 33106673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
